Global Patent Index - EP 4260067 A1

EP 4260067 A1 20231018 - PREDICTIVE BIOMARKERS FOR RISK OF BLADDER CANCER IN DIABETES PATIENTS

Title (en)

PREDICTIVE BIOMARKERS FOR RISK OF BLADDER CANCER IN DIABETES PATIENTS

Title (de)

PRÄDIKTIVE BIOMARKER FÜR BLASENKREBSRISIKO BEI DIABETESPATIENTEN

Title (fr)

BIOMARQUEURS PRÉDICTIFS DU RISQUE DE CANCER DE LA VESSIE CHEZ DES PATIENTS ATTEINTS DE DIABÈTE

Publication

EP 4260067 A1 20231018 (EN)

Application

EP 21839081 A 20211213

Priority

  • GB 202019663 A 20201214
  • EP 2021085424 W 20211213

Abstract (en)

[origin: WO2022128881A1] Herein we have identified a protein signature that is easily measured in blood and urine and highly predictive of bladder cancer (BC) risk in Type 2 Diabetes Mellitus (T2DM) patients. This biomarker model could be applied to screen T2DM patients presenting with haematuria for BC in diabetes clinics. Earlier urology referral of T2DM patients will improve outcomes for these patients.

IPC 8 full level

G01N 33/574 (2006.01)

CPC (source: EP)

G01N 33/57407 (2013.01); G01N 2333/4742 (2013.01); G01N 2333/475 (2013.01); G01N 2333/523 (2013.01); G01N 2333/5412 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022128881 A1 20220623; EP 4260067 A1 20231018; GB 202019663 D0 20210127

DOCDB simple family (application)

EP 2021085424 W 20211213; EP 21839081 A 20211213; GB 202019663 A 20201214